MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POLAND, A.
Right arrow Articles by KENDE, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POLAND, A.
Right arrow Articles by KENDE, A. S.

Molecular Pharmacology, Vol 18, 571-580, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

1,4-Bis[2-(3,5-Dichloropyridyloxy)]Benzene, a Potent Phenobarbital-Like Inducer of Microsomal Monooxygenase Activity

ALAN POLAND 1, IVAN MAK 1, EDWARD GLOVER 1, RODNEY J. BOATMAN 2, FRANK H. EBETINO 2, and ANDREW S. KENDE 2

1 McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706
2 Department of Chemistry, University of Rochester, Rochester, New York 14627

Sodium phenobarbital, diphenylhydantoin, dichiorophenobarbital, chlordane, mirex, and dieldrin, compounds which produce a similar pleiotropic response in the liver, were compared for their potency to induce hepatic aminopyrine N-demethylase activity in B6D2F1/J mice. The ED50, the dose which produces one-half the maximum enzyme induction when administered daily for 3 days, for phenobarbital is 1.07 x 10-4 mol/kg/ day, and for the most potent of these compounds, dieldrin, the ED50 is 8.0 x 10-6 mol/kg/ day. A new phenobarbital-like compound, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, (TCPOBOP), is 650 times as potent as phenobarbital, with an ED50 of 1.63 x 10-7 mol/ kg/day. Maximally effective doses of phenobarbital and TCPOBOP, administered alone or in combination, induce hepatic aminopyrine N-demethylase activity, cytochrome P-450, and NADPH-cytochrome c reductase to the same extent. The cytochrome(s) P-450 induced by these three treatments is similar by CO-difference spectra, ethyl isocyanide difference spectra, and SDS-polyacrylamide gel electrophoresis of liver microsomes. Both phenobarbital and TCPOBOP produce an increase in liver weight, proliferation of the smooth endoplasmic reticulum, and induction of microsomal epoxide hydrolase and cytosolic glutathione S-transferase activities. Both compounds induce microsomal monooxygenase activity in the proximal intestines, but not in kidney or skin. A single maximally effective dose of TCPOBOP (3 mg/kg) induces hepatic aminopyrine N-demethylase and microsomal epoxide hydrolase activities in B6D2F1/J mice for over 20 weeks. Following the administration of a single dose of 3H-TCPOBOP, radioactivity accumulates and is stored primarily in the adipose tissue and to a lesser extent in the liver. The radioactivity extracted from adipose tissue, 30 days after administration of the 3H-TCPOBOP, chromatographed as the parent compound. The hepatic concentration of TCPOBOP, after the administration of an ED50 dose, was estimated to be 1 x 10-7 M. TCPOBOP is a potent and long-acting phenobarbital-like inducer, a faithful mimic of this pleiotropic response for all measures tested. Despite the lack of a discernable structure-activity relationship among the numerous foreign compounds which evoke the phenobarbital pleiotropic response, the existence of a potent agonist, i.e., TCPOBOP, suggests that this response may be mediated through a specific recognition site.

Note:
ACKNOWLEDGMENT We gratefully acknowledge the help of Dr. Norman Drinkwater for writing a computer program for analyzing the dose-response curves and potency ratio.

Submitted on March 28, 1980
Accepted on June 16, 1980




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
W. Huang, J. Zhang, M. Washington, J. Liu, J. M. Parant, G. Lozano, and D. D. Moore
Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor
Mol. Endocrinol., June 1, 2005; 19(6): 1646 - 1653.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. L. Z. Dagli, H. Yamasaki, V. Krutovskikh, and Y. Omori
Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver
Carcinogenesis, April 1, 2004; 25(4): 483 - 492.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. A. Kocarek, J. M. Kraniak, and A. B. Reddy
Regulation of Rat Hepatic Cytochrome P450 Expression by Sterol Biosynthesis Inhibition: Inhibitors of Squalene Synthase Are Potent Inducers of CYP2B Expression in Primary Cultured Rat Hepatocytes and Rat Liver
Mol. Pharmacol., September 1, 1998; 54(3): 474 - 484.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics